Dong-A Socio Holdings has reported double-digit growth, driven by the performance of its key subsidiaries, Dong-A Pharmaceutical and Yongma Logistics.
On July 27, Dong-A Socio Holdings announced that its consolidated revenue for the second quarter reached 412.4 billion won, with an operating profit of 39 billion won. Revenue increased by 18.9% compared to the same period last year, while operating profit rose by 38.3%.
Dong-A Pharmaceutical, a healthcare specialist, saw its revenue grow by 25.7% to 228.2 billion won, thanks to strong sales of Bacchus and over-the-counter (OTC) products. Its operating profit also increased by 26.6% to 30.2 billion won.
Sales in the Bacchus and OTC segments rose by 26.6% and 36.5%, respectively, while the health functional food (HTC) segment grew by 4.4%.
Yongma Logistics, a logistics company, reported a 19.7% increase in revenue to 120.5 billion won, driven by an increase in existing client volumes and the acquisition of new clients. Its operating profit surged by 41.6% to 6.9 billion won.
In contrast, Biogen, a contract manufacturing organization (CMO) specializing in biopharmaceuticals, experienced a 45.2% decline in revenue to 13.7 billion won, as major client orders were concentrated in the second half of the year. Its operating profit plummeted by 90.0% to 400 million won.
For the first half of the year, Dong-A Socio Holdings reported consolidated revenue of 763.4 billion won, a 13.0% increase from the previous year, and an operating profit of 58.1 billion won, up 19.8%.
Dong-A Pharmaceutical's revenue rose by 18.3% to 416.2 billion won, with an operating profit increase of 24.7% to 50.8 billion won.
Yongma Logistics reported revenue of 231.1 billion won, a 14.6% increase, and an operating profit of 10.7 billion won, up 17.3%.
Biogen's revenue fell by 28.1% to 31.7 billion won, with an operating profit down 89.7% to 600 million won.
Additionally, Dong-A Socio Holdings announced on July 23 that it has resolved to absorb its wholly-owned subsidiary, Dong-A Pharmaceutical, in a board meeting. The merger is set to take place on October 1.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.